Indefinite Delivery Contract 75N93019D00012
Award Date
1/11/19
Last Date to Order
1/14/26
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The In Vitro Assessments of Antimicrobial Activity multiple award IDV was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to procure microbiology testing services in support of research related to infectious diseases and antimicrobial resistance. Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, received multiple firm fixed price and cost plus fixed fee delivery orders against the contract valued from $14K to $981K...
The Indefinite Delivery Contract (IDV) was awarded by the Department of the Army Medical Command to Laulima Government Solutions, LLC as a prime contractor. The IDV's parent master IDIQ is the USAMRIID Research and Development Support contract, with a potential value of $249 million over its period of performance from November 2015 to May 2021. Task orders issued under the IDV have procured scientific, technical, veterinary, medical research, and facilities support services from the contractor's...
The federal contract IDV award is a single-award Indefinite Delivery Contract issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Pharmacology Discovery Services Taiwan, LTD., a for-profit Taiwanese organization. The contract, valued up to $146.3M, supports NIAID's preclinical infectious disease research by providing a range of animal and animal replacement models for screening and evaluating candidate countermeasures such as therapeutics, vaccines,...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
This single-award IDV was issued by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide centralized clinical laboratory services in support of clinical research trials. With a potential value of $5,000,000 and a period of performance through May 2026, the awardee PPD Development LP will deliver services including specimen handling, testing, data management, and clinical trial support. The originating...
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is focused on providing pre-clinical models of infectious diseases to support research, development, and evaluation of medical countermeasures such as therapeutics, vaccines, and diagnostics. The contract has a single award to...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of Texas Health Science Center at San Antonio (UTHSCSA) to provide pre-clinical models of infectious diseases for up to $146.3 million over a period of 7 years. The contract supports NIAID's mission to understand, treat, and prevent infectious diseases by developing and refining small animal, non-human primate, and...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded multiple Indefinite Delivery/Indefinite Quantity contracts to provide preclinical development support for candidate products addressing HIV, HBV, HCV, and Mycobacterium tuberculosis. The total potential value of the IDV is $107,274,471 over seven years ending October 2027. Task orders have been issued under several areas. Lovelace Biomedical Research Institute received a $18,397 order to develop...
This is a single-award Indefinite Delivery Contract issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit organization that manufactures biologics. The Diagnostics Pre-Clinical Services Program IDIQ contract has a potential value of $24,000,000 over a 7-year ordering period ending June 2030. Under this contract, ABL will provide a broad range of preclinical diagnostic...
This Indefinite Delivery Contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to provide preclinical development support for candidate products and drug development activities ranging from initial product discovery to activities required for clinical trials and product licensure. The contract aims to fill critical development and resource gaps more rapidly and efficiently and advance promising products into clinical testing for HIV,...